Investors

This section of the website provides financial reports, investor presentations, information on key corporate transactions and much more.

We strive to be transparent, relevant and accurate in presenting our financial information, in order to inform our stakeholders of the company’s operations and financial position.

If you have any questions, please don’t hesitate to contact us at investors@c-rad.com
Svensk version här

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash
Learn more

Press releases

2023-08-21 12:30 Återköp av C-RAD B-aktier i vecka 33, 2023 News Corporate Action Shares Repurchase Swedish Regulatory Listing Regulation IR
2023-08-14 09:15 Breast cancer treatment option with surface guidance now available for clinical use in U.S. News Corporate Information Other Corporate Information English IR
2023-07-31 16:00 Tidigare anställd överklagar dom från Patent- och marknadsöverdomstolen News Corporate Information Other Corporate Information Swedish IR
2023-07-31 16:00 Former employee appeals verdict from the Patent and Market court of appeal News Corporate Information Other Corporate Information English IR
2023-07-20 08:30 Stark intäktstillväxt och förbättrad lönsamhet News Swedish Regulatory MAR VPML Report Interim Q2 IR
2023-07-20 08:30 Strong revenue growth and improved profitability News English Regulatory MAR VPML Report Interim Q2 IR

Shares & stock

Please feel free to contact us regarding investments or other financial questions

If you have any questions, please don’t hesitate to contact us